查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1654678

全球側韌帶穩定系統市場 - 2025 至 2033 年

Global Collateral Ligament Stabilizer System Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球側韌帶穩定系統市場規模達到 23.2 億美元，預計到 2033 年將達到 41.1 億美元，在 2025-2033 年預測期內的複合年成長率為 6.5%。

側韌帶穩定系統是一種專門的醫療設備，旨在為膝關節受傷或衰弱的側韌帶提供支撐、穩定性和調整。這些韌帶，包括內側副韌帶 (MCL) 和外側副韌帶 (LCL)，透過防止過度的左右運動在維持關節穩定性方面發揮至關重要的作用。這些韌帶的損傷在運動相關活動、事故或因退化狀況而發生很常見，導致疼痛、腫脹和關節不穩定。

市場動態：

促進因素與約束因素

運動傷害發生率不斷上升

由於全球運動相關傷害（尤其是膝蓋傷害）的增加，側韌帶穩定系統市場正在成長。足球、籃球、滑雪和橄欖球等高強度運動需要快速改變方向和身體接觸，因此運動員容易受到傷害。健身潮流和競技運動的火爆，進一步增加了韌帶相關損傷的風險。這推動了對先進穩定系統的需求，以幫助運動員更快地恢復、保持關節穩定並降低再次受傷的風險。

例如，日本大學運動員運動傷害的發生率很高，其中一半報告受傷，45％報告多次受傷。這一比例超過了其他國家報告的普通人群和體育人群的數字。在德國，3.1% 的成年人報告在過去一年中遭受運動傷害，而在丹麥，18.4% 的成年人和 19.3% 的兒童報告在過去 12 個月內遭受運動傷害。芬蘭青少年報告稱，在過去一年中至少發生過一次急性或過度使用損傷。巴西運動員報告稱，在其 6 至 10 年的醫學研究中，受傷發生率為 49%，而不是像目前研究中的運動員一樣在一年內發生。

新興地區的認知有限和診斷延遲

由於對韌帶損傷的認知有限和診斷延遲，側韌帶穩定系統市場面臨挑戰，尤其是在新興和低度開發地區。農村居民可能無法認知到傷害的嚴重性或將症狀歸咎於輕微的拉傷，從而導致延誤尋求適當的醫療救治。缺乏專業的骨科護理和診斷設施進一步導致診斷不足和治療不足，減少了對穩定系統的需求並阻礙了市場成長。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 運動傷害發生率不斷上升
    • 限制
      • 新興地區的認知有限和診斷延遲
    • 機會
    • 影響分析

第5章：產業分析

  • 波特五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章：按韌帶類型

  • 內側副韌帶 (MCL)
  • 外側副韌帶 (LCL)

第 7 章：按傷害類型

  • 一級（輕度）
  • 二級（中）
  • 三級（嚴重）

第 8 章：按最終用戶

  • 醫院
  • 骨科診所
  • 其他

第9章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 10 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 11 章：公司簡介

  • Bauerfeind.
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 關鍵進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • Enovis (DJO Global, Inc.)
  • DeRoyal Industries
  • Ossur hf.
  • DARCO International, Inc.
  • Orthofix US LLC (Breg, Inc.)
  • Thuasne USA
  • Bio Dynamic Technologies
  • BSN Medical
  • Similar data will be provided for each market player.
  • 布雷格公司
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 科林集團
  • 將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄
Product Code: MD9128

The Global Collateral Ligament Stabilizer System Market reached US$ 2.32 Billion in 2024 and is expected to reach US$ 4.11 Billion by 2033, growing at a CAGR of 6.5% during the forecast period 2025-2033.

The Collateral Ligament Stabilizer System is a specialized medical device designed to provide support, stability, and alignment to injured or weakened collateral ligaments, primarily in the knee joint. These ligaments, including the medial collateral ligament (MCL) and lateral collateral ligament (LCL), play a crucial role in maintaining the joint's stability by preventing excessive side-to-side movements. Injuries to these ligaments are common in sports-related activities, accidents, or due to degenerative conditions, leading to pain, swelling, and joint instability.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Sports-related Injuries

The Collateral Ligament Stabilizer System market is growing due to the rise in sports-related injuries globally, particularly in knees. High-impact sports like football, basketball, skiing, and rugby involve rapid directional changes and physical contact, making athletes susceptible. The popularity of fitness trends and competitive sports has further increased the risk of ligament-related injuries. This has driven the demand for advanced stabilizer systems that aid in faster recovery, joint stability, and reduced risk of reinjury in athletes.

For instance, The prevalence of sports injuries among Japanese collegiate athletes is high, with half reporting an injury and 45% sustaining multiple injuries. This rate exceeds numbers reported for general and sports populations in other countries. In Germany, 3.1% of adults reported sustaining a sports injury in the previous year, while in Denmark, 18.4% of adults and 19.3% of children reported having a sports injury within the past 12 months. Finnish adolescents reported at least one acute or overuse injury in the previous year. Brazilian athletes reported an injury prevalence of 49% over 6-10 years of their medical studies, not within a year like the athletes in the current study.

Limited Awareness and Delayed Diagnosis in Emerging Regions

The collateral ligament stabilizer system market faces challenges due to limited awareness and delayed diagnosis of ligament injuries, particularly in emerging and underdeveloped regions. Rural individuals may not recognize the severity of injuries or attribute symptoms to minor strains, leading to delays in seeking proper medical attention. Lack of access to specialized orthopedic care and diagnostic facilities further contributes to underdiagnosis and undertreatment, reducing demand for stabilizer systems and hindering market growth.

Segment Analysis

The global Collateral Ligament Stabilizer System market is segmented based on, Ligament Type, Injury Type, End User and Region.

Ligament Type:

Medial Collateral Ligament (MCL) segment is expected to dominate the Collateral Ligament Stabilizer System market share

The medial collateral ligament (MCL) segment holds a major portion of the Collateral Ligament Stabilizer System market share and is expected to continue to hold a significant portion of the Collateral Ligament Stabilizer System market share during the forecast period.

The Medial Collateral Ligament (MCL) is a crucial ligament in the knee joint, connecting the femur to the tibia and resisting valgus forces. Injuries to the MCL are common, especially in contact sports like football, hockey, and skiing. The increasing prevalence of MCL injuries has led to a demand for Collateral Ligament Stabilizer Systems, designed to provide targeted support, reduce stress, and promote healing. As awareness of sports-related injuries increases and diagnostic techniques improve, the focus on MCL-specific stabilizers continues to drive market growth.

End User:-

Hospitals segment is the fastest-growing segment in Collateral Ligament Stabilizer System market share

The hospitals segment is the fastest-growing segment in the Collateral Ligament Stabilizer System market share and is expected to hold the market share over the forecast period.

Hospitals are key players in the Collateral Ligament Stabilizer System market, providing diagnosis, treatment, and rehabilitation for ligament injuries. They use advanced imaging technologies and specialized orthopedic departments for early detection and management. Hospitals perform numerous surgical procedures, particularly in severe ligament tears requiring post-operative support. The presence of skilled healthcare professionals and comprehensive rehabilitation programs drives the adoption of advanced stabilizer systems. The growing number of sports injury cases and improvements in hospital infrastructure further contribute to the market's growth.

Geographical Analysis

North America is expected to hold a significant position in the Collateral Ligament Stabilizer System market share

North America holds a substantial position in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share due to high sports-related injuries and increasing orthopedic procedures. The region's strong sports culture, advanced medical technologies, and awareness about injury management contribute to market growth. Favourable reimbursement policies, extensive research and development activities, and key market players further accelerate the adoption of advanced stabilizer systems in the region. The region's well-established healthcare infrastructure and advanced medical technologies further drive market growth.

For instance, according to The Johns Hopkins Hospital, and Johns Hopkins Health System, over 3.5 million children aged 14 and younger are injured annually in sports or recreational activities, with brain injuries being the leading cause of death. Sports and recreational activities contribute to 21% of all traumatic brain injuries among American children. Almost 50% of head injuries in sports or recreational activities occur during incidents like bicycling, skateboarding, or skating. Over 775,000 children are treated for sports-related injuries annually, primarily due to falls, object strikes, collisions, and overexertion during unorganized or informal sports activities.

Europe is growing at the fastest pace in the Collateral Ligament Stabilizer System market

Europe holds the fastest pace in the Collateral Ligament Stabilizer System market and is expected to hold most of the market share is due to the growing focus on sports injury prevention and rehabilitation, orthopedic care advancements, and the popularity of activities like soccer, skiing, and rugby. Strong healthcare policies, government initiatives, and access to innovative medical devices like CE marking contribute to market growth. The aging population and collaborations between research institutions and medical device companies further support the market expansion across Europe.

For instance, according to The Johns Hopkins Hospital Sports injuries in the UK are prevalent, with around 2 million people visiting Accident & Emergency departments annually due to these injuries, resulting from various activities such as team sports like football and rugby, as well as individual physical activities like running and gym workouts.

Competitive Landscape

The major global players in the Collateral Ligament Stabilizer System market include Bauerfeind, Enovis (DJO Global, Inc.), DeRoyal Industries, Ossur hf, DARCO International, Inc., Orthofix US LLC (Breg, Inc.), Thuasne USA, Bio Dynamic Technologies, BSN Medical and among others.

Key Developments

  • In January 2024, Enovis has acquired Limacorporate, a company specializing in orthopedic implants, thereby strengthening its market dominance in the rapidly growing extremities market segment, with the acquisition of Limacorporate's 3D-printed Trabecular Titanium implants.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Collateral Ligament Stabilizer System market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 210 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Ligament Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Ligament Type
  • 3.2. Snippet by Injury Type
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Sports-related Injuries
    • 4.1.2. Restraints
      • 4.1.2.1. Limited Awareness and Delayed Diagnosis in Emerging Regions
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis

6. By Ligament Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 6.1.2. Market Attractiveness Index, By Ligament Type
  • 6.2. Medial Collateral Ligament (MCL)*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Lateral Collateral Ligament (LCL)

7. By Injury Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 7.1.2. Market Attractiveness Index, By Injury Type
  • 7.2. Grade I (Mild)*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Grade II (Moderate)
  • 7.4. Grade III (Severe)

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Orthopedic Clinics
  • 8.4. Others

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Ligament Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Injury Type
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Bauerfeind.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Enovis (DJO Global, Inc.)
  • 11.3. DeRoyal Industries
  • 11.4. Ossur hf.
  • 11.5. DARCO International, Inc.
  • 11.6. Orthofix US LLC (Breg, Inc.)
  • 11.7. Thuasne USA
  • 11.8. Bio Dynamic Technologies
  • 11.9. BSN Medical
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.10. Breg, Inc*
    • 11.10.1. Pipeline Products Description
    • 11.10.2. Product Key Performance Indicators (KPIs)
    • 11.10.3. Key Activities
    • 11.10.4. Market Entry Timelines
    • 11.10.5. Product Penetration Rate
    • 11.10.6. Sales Estimation and Projections
  • 11.11. Corin Group
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us